Filing Details
- Accession Number:
- 0001140361-17-034739
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-07 16:54:02
- Reporting Period:
- 2017-09-05
- Accepted Time:
- 2017-09-07 16:54:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1561387 | Health Insurance Innovations Inc. | HIIQ | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1366008 | Sheldon Wang | C/O Health Insurance Innovations, Inc. 15438 N. Florida Ave., Suite 201 Tampa FL 33613 | Chief Technology Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2017-09-05 | 5,000 | $4.95 | 229,001 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2017-09-05 | 799 | $30.95 | 228,202 | No | 4 | D | Direct | |
Class A Common Stock | Disposition | 2017-09-05 | 4,201 | $30.95 | 224,001 | No | 4 | S | Direct | |
Class A Common Stock | Acquisiton | 2017-09-06 | 5,000 | $4.95 | 229,001 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2017-09-06 | 779 | $31.80 | 228,222 | No | 4 | D | Direct | |
Class A Common Stock | Disposition | 2017-09-06 | 4,221 | $31.80 | 224,001 | No | 4 | S | Direct | |
Class A Common Stock | Acquisiton | 2017-09-06 | 5,000 | $6.77 | 229,001 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2017-09-06 | 1,065 | $3,180.00 | 227,936 | No | 4 | D | Direct | |
Class A Common Stock | Disposition | 2017-09-06 | 3,935 | $31.80 | 224,001 | No | 4 | S | Direct | |
Class A Common Stock | Acquisiton | 2017-09-06 | 5,000 | $6.77 | 229,001 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2017-09-06 | 1,050 | $32.25 | 227,951 | No | 4 | D | Direct | |
Class A Common Stock | Disposition | 2017-09-06 | 3,950 | $32.25 | 224,001 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | D | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | D | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | D | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | D | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Stock Appreciation Rights | Disposition | 2017-09-05 | 5,000 | $0.00 | 5,000 | $4.95 |
Common Stock | Stock Appreciation Rights | Disposition | 2017-09-06 | 5,000 | $0.00 | 5,000 | $4.95 |
Common Stock | Stock Appreciation Rights | Disposition | 2017-09-06 | 10,000 | $0.00 | 10,000 | $6.77 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
25,000 | 2022-07-01 | No | 4 | M | Direct | |
20,000 | 2022-07-01 | No | 4 | M | Direct | |
31,039 | 2021-05-25 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Class A Common Stock | Stock Appreciation Rights | $12.13 | 2021-07-14 | 6,000 | 6,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2021-07-14 | 6,000 | 6,000 | Direct |
Footnotes
- These stock-settled stock appreciation rights were previously granted under the Plan and are scheduled to vest in increments of 25%, 25%, and 50% on successive anniversary dates of the grant, subject to the terms of the Plan and an award agreement under the Plan.
- These stock-settled stock appreciation rights were granted under the Issuer's Long Term Incentive Plan (the "Plan") and are vested as of the date of this Form 4.
- These stock-settled stock appreciation rights were previously granted under the Plan and are scheduled to vest in increments of 20%, 20%, 20%, and 40% on successive anniversary dates of the grant, subject to the terms of the plan and an award agreement under the plan.
- Shares retained by the issuer to satisfy the exercise price of stock appreciation rights exercised by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.25 to $32.275, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth.